The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C09 | Agents acting on the renin-angiotensin system | |
| 3 | C09D | Angiotensin II antagonists, combinations | |
| 4 | C09DX | Angiotensin II antagonists, other combinations |
| Code | Title | |
|---|---|---|
| C09DX01 | Valsartan, amlodipine and hydrochlorothiazide | |
| C09DX02 | Valsartan and aliskiren | |
| C09DX03 | Olmesartan medoxomil, amlodipine and hydrochlorothiazide | |
| C09DX04 | Valsartan and sacubitril | |
| C09DX05 | ||
| C09DX06 | ||
| C09DX07 | ||
| C09DX08 |
| Active Ingredient | Description | |
|---|---|---|
| Valsartan and Sacubitril |
|
|
| Valsartan, Amlodipine and Hydrochlorothiazide |
Combination of three antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine that belongs to the calcium antagonist class and valsartan that belongs to the angiotensin II antagonist class of medicines and hydrochlorothiazide that belongs to the thiazide diuretics class of medicines. The combination of these substances has an additive antihypertensive effect. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| COPALIA HCT Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ENTRESTO Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
